Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YY-20394 in relapsed/refractory follicular lymphoma
CTR20182094Phase 2Completed
- Sponsor
- Yingli Pharma
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linperlisib in follicular lymphoma (FL), sponsored by Yingli Pharma. Started Jul 2019; status: completed.
02
Drugs
linperlisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on CTR20182094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182094.